NPPES file of Aug 9, 2026

Matthew Rettig, MD

Hematology & Oncology Physician · Los Angeles, CA

Matthew Rettig, MD is a hematology & oncology physician with a practice address in Los Angeles, California, and NPI 1487751798, issued on Sep 20, 2006. Check the license (California A52586, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1487751798
Name
Matthew Rettig
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
A52586 CA
Self-reported in NPPES; status is on the state search
Practice location
200 Ucla Medical Plz Ste 140, Los Angeles, CA 90095
Phone
(310) 794-7152
Enumerated
Sep 20, 2006
Record last updated
Jan 9, 2020 (not updated in 6 years: call before relying on the address or phone)
Fax
(310) 794-1666
Medicaid ID
00A525860 CA
Medicare enrollment
Enrolled (PECOS I20070915000192); accepts Medicare assignment
Medical or professional school
Duke University School Of Medicine, 1990
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 200 Ucla Medical Plz Ste 140

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Anne Ackerman, M.D.Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician1760610711
  2. Linda Allahyarian, NPFamily Nurse Practitioner1063149946
  3. Juan Andino, MDUrology Physician1053846584
  4. Jeremy Blumberg, M.D.Urology Physician1982889622
  5. Wayne Brisbane, M.D.Urology Physician1346583176
  6. Michelle Cardenas, NPNurse Practitioner1548036817

Verify Matthew Rettig in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMedical Board of California
    Search for license A52586
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

9% more Medicare Part D claims than the average hematology & oncology physician in 2024

956 Medicare Part D claims for 98 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 65% of claims.

  1. Matthew Rettig956
  2. Specialty average877

Most prescribed

  1. Nubeqa220 claims
  2. Xtandi161 claims
  3. Orgovyx125 claims
  4. Erleada97 claims
  5. Abiraterone Acetate94 claims
  6. Prednisone61 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 81.1 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score70.9
  2. Costout of 100 · 30%57.6
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $22,567.81

41 payments; by number, the most common kind was food and beverage; the largest payer was Janssen Biotech, Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Matthew Rettig$22,568
  2. Specialty average$7,481

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. The Regents OF The University OF CaliforniaLos Angeles, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Matthew Rettig among 1,583 hematology & oncology physician records in California

Matthew Rettig, MD is one of 1,583 hematology & oncology physician records with a practice address in California. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 8% of them.

  • NPI issued2006 · 8% of these records are older, 54% newer
  • In a Medicare fileYes · 83% of these records are
  • In the CMS Doctors and Clinicians fileYes · 71% of these records are
  • Graduated1990 · median 2003 among the 1,124 with a school on file
  • Record last updated2020 · 58% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in California

There are 1,583 hematology & oncology physician records in California.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. David Chang, MDLos Angeles, CA 900951952336737
  2. Grace Cherry, NPLos Angeles, CA 900951659306447
  3. Sven De Vos, MDLos Angeles, CA 900951528093713
  4. Aryeh Edelist, MDLos Angeles, CA 900951437184629
  5. Christos Emmanouilides, MDLos Angeles, CA 900951780600619
  6. Nancy Feldman, MDLos Angeles, CA 900951538184700
  7. Jennifer Gansert, MDLos Angeles, CA 900951811922412
  8. Patricia Ganz, MDLos Angeles, CA 900951871528471

Common questions

What is Matthew Rettig, MD's NPI number?

Matthew Rettig, MD's National Provider Identifier (NPI) is 1487751798, issued on Sep 20, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Matthew Rettig, MD located?

The NPPES record lists a practice address at 200 Ucla Medical Plz Ste 140, Los Angeles, CA, 90095. Phone: (310) 794-7152. Providers update this record themselves, so call before visiting.

How can I verify Matthew Rettig, MD's license?

NPPES lists California license number A52586, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Matthew Rettig, MD prescribe under Medicare Part D?

In 2024, Matthew Rettig, MD had 956 Medicare Part D claims for 98 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Matthew Rettig, MD's MIPS final score?

The 2023 MIPS final score is 81.1 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.